• Explore /
  • Poster
  • / ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/gem).

ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/gem).

Abstract Poster

Authors

Mairead McNamara

Mairead Geraldine McNamara

University of Manchester/The Christie NHS Foundation Trust, Manchester, United Kingdom

Mairead Geraldine McNamara , Hayley Timmins , Ashley Osborne , Rebecca Cox , Harpreet Singh Wasan , Pippa Corrie , Roopinder Gillmore , Shivan Sivakumar , Yuk Ting Ma , Olusola Olusesan Faluyi , Arvind Arora , Seema Arif , Jo Canham , Chris Hurt , Richard Hubner , John A Bridgewater , Richard Adams , Juan W. Valle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

11210442

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS4183)

DOI

10.1200/JCO.2023.41.16_suppl.TPS4183

Abstract #

TPS4183

Poster Bd #

498a

Abstract Disclosures

Similar Posters

First Author: Wei Li

First Author: Jieer Ying

First Author: Richard D. Kim

First Author: Raed Moh'd Taiseer Al-Rajabi